Published in Emerg Infect Dis on December 01, 2004
Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis (2009) 1.03
Diagnosis of west nile virus human infections: overview and proposal of diagnostic protocols considering the results of external quality assessment studies. Viruses (2013) 0.91
Assay optimization for molecular detection of Zika virus. Bull World Health Organ (2016) 0.90
Follow-up on diagnostic proficiency of laboratories equipped to perform orthopoxvirus detection and quantification by PCR: the second international external quality assurance study. J Clin Microbiol (2006) 0.86
Performance of the RealStar Chikungunya virus real-time reverse transcription-PCR kit. J Clin Microbiol (2009) 0.79
Automated extraction protocol for quantification of SARS-coronavirus RNA in serum: an evaluation study. BMC Infect Dis (2006) 0.78
Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA. Ann Lab Med (2017) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88
Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem (2003) 1.67
Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem (2004) 1.55
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2004) 1.40
First international quality assurance study on the rapid detection of viral agents of bioterrorism. J Clin Microbiol (2004) 1.33
Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003. Emerg Infect Dis (2004) 1.21
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med (2004) 11.31
Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol (2005) 7.88
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J Infect Dis (2002) 5.92
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med (2006) 5.14
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Lung pathology of fatal severe acute respiratory syndrome. Lancet (2003) 5.02
Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol (2003) 4.66
Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis (2009) 4.25
Virology: SARS virus infection of cats and ferrets. Nature (2003) 3.86
Low frequency of poultry-to-human H5NI virus transmission, southern Cambodia, 2005. Emerg Infect Dis (2006) 2.98
Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis (2009) 2.60
Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem (2006) 2.32
Avian influenza and pandemics--research needs and opportunities. N Engl J Med (2005) 2.18
Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol (2005) 2.09
Role of quail in the interspecies transmission of H9 influenza A viruses: molecular changes on HA that correspond to adaptation from ducks to chickens. J Virol (2003) 2.07
Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis (2011) 2.03
Influenza A/H5N1 virus infection in humans in Cambodia. J Clin Virol (2007) 1.97
S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients. J Virol (2004) 1.80
The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet (2006) 1.79
Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol (2004) 1.74
Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. Lancet Infect Dis (2011) 1.66
Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol (2009) 1.65
Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65
Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect (2002) 1.64
A clear and present danger: tick-borne diseases in Europe. Expert Rev Anti Infect Ther (2010) 1.61
Preventing and treating influenza. BMJ (2003) 1.57
Phylogeny of the SARS coronavirus. Science (2003) 1.56
Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay. J Virol Methods (2003) 1.54
Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis (2002) 1.54
Coronavirus antibodies in African bat species. Emerg Infect Dis (2007) 1.54
Detection of yellow fever 17D genome in urine. J Clin Microbiol (2010) 1.52
Detection of West Nile virus lineages 1 and 2 by real-time PCR. J Virol Methods (2007) 1.49
Alkhumra, not Alkhurma, is the correct name of the new hemorrhagic fever flavivirus identified in Saudi Arabia. Intervirology (2012) 1.48
Multicentre evaluation of central nervous system infections due to Flavi and Phleboviruses in Turkey. J Infect (2012) 1.43
Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J Clin Microbiol (2002) 1.42
The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine (2005) 1.42
Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol (2003) 1.39
Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. J Clin Virol (2009) 1.39
Dengue virus infection in travellers returning to Berlin, Germany: clinical, laboratory, and diagnostic aspects. Acta Trop (2004) 1.39
WHO global salm-surv external quality assurance system (EQAS): an important step toward improving the quality of Salmonella serotyping and antimicrobial susceptibility testing worldwide. Microb Drug Resist (2002) 1.38
Emergence of new norovirus variants on spring cruise ships and prediction of winter epidemics. Emerg Infect Dis (2008) 1.35
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med (2006) 1.34
Reversal of P-glycoprotein-mediated multidrug resistance by the murine double minute 2 antagonist nutlin-3. Cancer Res (2009) 1.34
2nd International external quality control assessment for the molecular diagnosis of dengue infections. PLoS Negl Trop Dis (2010) 1.34
Analysis of two imported cases of yellow fever infection from Ivory Coast and The Gambia to Germany and Belgium. J Clin Virol (2005) 1.33
Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci Transl Med (2009) 1.32
A novel reovirus isolated from a patient with acute respiratory disease. J Clin Virol (2009) 1.32
Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol (2013) 1.27
Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles. J Virol (2010) 1.27
Evaluation of the first commercial chikungunya virus indirect immunofluorescence test. J Virol Methods (2008) 1.26
Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol (2012) 1.23
SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis (2004) 1.23
Prevalence of antibodies against avian influenza A (H5N1) virus among Cullers and poultry workers in Ho Chi Minh City, 2005. PLoS One (2009) 1.23
Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J Vet Med Sci (2004) 1.21
Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. J Med Virol (2010) 1.21
Avian influenza H5N1 and healthcare workers. Emerg Infect Dis (2005) 1.20
Histone deacetylase inhibitors suppress natural killer cell cytolytic activity. FEBS Lett (2007) 1.20
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis (2005) 1.19
Performance of laboratory diagnostics for the detection of influenza A(H1N1)v virus as correlated with the time after symptom onset and viral load. J Clin Virol (2010) 1.19
Avian influenza and influenza pandemics. Bull World Health Organ (2004) 1.15
Quality control assessment for the serological diagnosis of dengue virus infections. J Clin Virol (2004) 1.14
Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med (2003) 1.13
Serologic evidence of West Nile virus infections in wild birds captured in Germany. Am J Trop Med Hyg (2007) 1.12
The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011. Influenza Other Respir Viruses (2012) 1.12
Valproic acid as anti-cancer drug. Curr Pharm Des (2007) 1.11
Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother (2007) 1.11
Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. J Clin Virol (2015) 1.11
Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. Trends Mol Med (2004) 1.11
Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol (2007) 1.10
Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochem Pharmacol (2009) 1.09
External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol (2004) 1.09
Factors affecting patterns of tick parasitism on forest rodents in tick-borne encephalitis risk areas, Germany. Parasitol Res (2010) 1.09
Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: epidemiological, clinical, and laboratory characteristics. J Infect (2010) 1.08
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. J Virol (2005) 1.08
Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis (2003) 1.07
Epidemiology and clinical features of sporadic hepatitis E as compared with hepatitis A. Am J Gastroenterol (2006) 1.06
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS One (2011) 1.06
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005. Vaccine (2006) 1.05
Characterisation of human tick-borne encephalitis virus from Sweden. J Med Virol (2003) 1.05
Tick burden on European roe deer (Capreolus capreolus). Exp Appl Acarol (2010) 1.05
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression. J Infect Dis (2002) 1.05
SARS transmission and commercial aircraft. Emerg Infect Dis (2004) 1.04
Coordinated implementation of chikungunya virus reverse transcription-PCR. Emerg Infect Dis (2009) 1.03
Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein. J Virol (2004) 1.03
Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed? Med Microbiol Immunol (2009) 1.03
First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion (2009) 1.02
Type 1 diabetes in Swedish bank voles (Clethrionomys glareolus): signs of disease in both colonized and wild cyclic populations at peak density. Ann N Y Acad Sci (2003) 1.00
Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma. Cancer Res (2003) 0.99
Molecular assays for monitoring HIV infection and antiretroviral therapy. Expert Rev Mol Diagn (2007) 0.98
Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill (2015) 0.97